Behavior of hospitalized severe influenza cases according to the outcome variable in Catalonia, Spain, during the 2017-2018 season

dc.contributor.authorSoldevila, Núria
dc.contributor.authorAcosta, Lesly
dc.contributor.authorMartínez Rodríguez, Ana
dc.contributor.authorGodoy, Pere
dc.contributor.authorTorner Gràcia, Núria
dc.contributor.authorRius, Cristina
dc.contributor.authorJane, Mireia
dc.contributor.authorDomínguez García, Àngela
dc.date.accessioned2022-06-21T17:20:41Z
dc.date.available2022-06-21T17:20:41Z
dc.date.issued2021-06-30
dc.date.updated2022-06-21T17:20:41Z
dc.description.abstractInfuenza is an important cause of severe illness and death among patients with underlying medical conditions and in the elderly. The aim of this study was to investigate factors associated with ICU admission and death in patients hospitalized with severe laboratory-confrmed infuenza during the 2017-2018 season in Catalonia. An observational epidemiological case-to-case study was carried out. Reported cases of severe laboratory-confrmed infuenza requiring hospitalization in 2017-2018 infuenza season were included. Mixed-efects regression analysis was used to estimate the factors associated with ICU admission and death. A total of 1306 cases of hospitalized severe infuenza cases were included, of whom 175 (13.4%) died and 217 (16.6%) were ICU admitted. Age 65-74 years and≥ 75 years and having≥ 2 comorbidities were positively associated with death (aOR 3.19; 95%CI 1.19-8.50, aOR 6.95, 95%CI 2.76-1.80 and aOR 1.99; 95%CI 1.12-3.52, respectively). Neuraminidase inhibitor treatment and pneumonia were negatively associated with death. The 65-74 years and≥ 75 years age groups were negatively associated with ICU admission (aOR 0.41; 95%CI 0.23-0.74 and aOR 0.30; 95%CI 0.17-0.53, respectively). A factor positively associated with ICU admission was neuraminidase inhibitor treatment. Our results support the need to investigate the worst outcomes of hospitalized severe cases, distinguishing between death and ICU admission.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec713673
dc.identifier.issn2045-2322
dc.identifier.pmid34642443
dc.identifier.urihttps://hdl.handle.net/2445/186871
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41598-021-92895-5
dc.relation.ispartofScientific Reports, 2021, vol. 11, p. 13587
dc.relation.urihttps://doi.org/10.1038/s41598-021-92895-5
dc.rightscc-by (c) Soldevila, Núria et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationGrip
dc.subject.classificationUnitats de cures intensives
dc.subject.classificationMedicaments antivírics
dc.subject.classificationPneumònia
dc.subject.otherInfluenza
dc.subject.otherIntensive care units
dc.subject.otherAntiviral agents
dc.subject.otherPneumonia
dc.titleBehavior of hospitalized severe influenza cases according to the outcome variable in Catalonia, Spain, during the 2017-2018 season
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
713673.pdf
Mida:
1.38 MB
Format:
Adobe Portable Document Format